Researchers from the University of Pittsburgh School of Medicine report a significant new advance in the search for an effective treatment for human liver cancer in the July issue of Molecular Cancer Therapeutics.
A molecularly engineered therapy selectively embeds a gene in pancreatic cancer that shrinks or eradicates tumors, inhibits metastasis, and prolongs survival with virtually no toxicity, researchers from The University of Texas M. D. Anderson Cancer Center report in the July 9 edition of Cancer Cell.
Putting bacteria on birth control could stop the spread of drug-resistant microbes, and researchers at the University of North Carolina at Chapel Hill have found a way to do just that.
Exelon?Patch (rivastigmine transdermal system) has received its first worldwide approval in the United States as an innovative way to deliver an effective medicine for mild to moderate Alzheimer’s disease patients through a skin patch instead of an oral capsule.
Health Canada is warning Canadians that counterfeit toothpaste products, falsely labelled as Colgate Fluoride Toothpaste Herbal and Colgate Fluoride Toothpaste Maximum Cavity Protection, have been found to contain high levels of harmful bacteria.
The U.S. Food and Drug Administration is warning consumers not to eat Veggie Booty snack food, marketed by Robert’s American Gourmet, due to possible contamination with Salmonella Wandsworth, bacteria that cause gastrointestinal illness.
Use of certain antidepressants, selective serotonin-reuptake inhibitors most commonly known as SSRIs, during pregnancy does not significantly increase the risk for most birth defects, according to a new Centers for Disease Control and Prevention (CDC) study, released in the New England Journal of Medicine (NEJM).
In a study involving unannounced visits by actors portraying new patients, primary care physicians shared personal information about one-third of the time, according to a report in the June 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Only 10 (14 percent) of these disclosures were in response to a patient question, and most (62, or 85 percent) appeared not to be useful to the patient.
More than 300,000 patients receive mechanical ventilation during intensive care per year in the United States, even though the hospital mortality rate for ventilated patients can approach 50 percent. New findings indicate that medical patients with an alcohol-use disorder (AUD) are more likely to require mechanical ventilation, and/or need it for a longer period of time.
Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee did not recommend approval of rimonabant (ZIMULTI(R)) to the US FDA for use in obese and overweight patients with associated risks factors.